Establishment of a hepatic cirrhosis and portal hypertension model by hepatic arterial perfusion with 80% alcohol

被引:9
作者
Wang, Lei [1 ]
He, Fu-Liang [1 ]
Liu, Fu-Quan [1 ]
Yue, Zhen-Dong [1 ]
Zhao, Hong-Wei [1 ]
机构
[1] Capital Med Univ, Beijing Shijitan Hosp, Dept Intervent Therapy, Beijing 100038, Peoples R China
关键词
Alcohol; Hepatic arterial perfusion; Hepatic cirrhosis; Portal hypertension; Animal model; ANIMAL-MODELS; LIVER; FIBROSIS; RATS; SWINE; SUPPLEMENTATION; TRANSARTERIAL; EMBOLIZATION; MECHANISMS; SORAFENIB;
D O I
10.3748/wjg.v21.i32.9544
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To determine the feasibility and safety of establishing a porcine hepatic cirrhosis and portal hypertension model by hepatic arterial perfusion with 80% alcohol. METHODS: Twenty-one healthy Guizhou miniature pigs were randomly divided into three experimental groups and three control groups. The pigs in the three experimental groups were subjected to hepatic arterial perfusion with 7, 12 and 17 mL of 80% alcohol, respectively, while those in the three control groups underwent hepatic arterial perfusion with 7, 12 and 17 mL of saline, respectively. Hepatic arteriography and direct portal phlebography were performed on all animals before and after perfusion, and the portal venous pressure and diameter were measured before perfusion, immediately after perfusion, and at 2, 4 and 6 wk after perfusion. The following procedures were performed at different time points: routine blood sampling, blood biochemistry, blood coagulation and blood ammonia tests before surgery, and at 2, 4 and 6 wk after surgery; hepatic biopsy before surgery, within 6 h after surgery, and at 1, 2, 3, 4 and 5 wk after surgery; abdominal enhanced computed tomography examination before surgery and at 6 wk after surgery; autopsy and multi-point sampling of various liver lobes for histological examination at 6 wk after surgery. RESULTS: In experimental group 1, different degrees of hepatic fibrosis were observed, and one pig developed hepatic cirrhosis. In experimental group 2, there were cases of hepatic cirrhosis, different degrees of increased portal venous pressure, and intrahepatic portal venous bypass, but neither extrahepatic portal-systemic bypass circulation nor death occurred. In experimental group 3, two animals died and three animals developed hepatic cirrhosis, and different degrees of increased portal venous pressure and intrahepatic portal venous bypass were also observed, but there was no extrahepatic portal-systemic bypass circulation. CONCLUSION: It is feasible to establish an animal model of hepatic cirrhosis and portal hypertension by hepatic arterial perfusion with 80% alcohol, however, the safety of this model depends on a suitable perfusion dose.
引用
收藏
页码:9544 / 9553
页数:10
相关论文
共 21 条
  • [1] Albedano Antonanzas D, 1990, REV ENFERM, V13, P32
  • [2] Development of a Large Animal Model of Cirrhosis and Portal Hypertension Using Hepatic Transarterial Embolization: A Study in Swine
    Avritscher, Rony
    Wright, Kenneth C.
    Javadi, Sanaz
    Uthamanthil, Rajesh
    Gupta, Sanjay
    Gagea, Mihai
    Bassett, Roland L.
    Murthy, Ravi
    Wallace, Michael J.
    Madoff, David C.
    [J]. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2011, 22 (09) : 1329 - 1334
  • [3] Sorafenib treatment improves hepatopulmonary syndrome in rats with biliary cirrhosis
    Chang, Ching-Chih
    Chuang, Chiao-Lin
    Lee, Fa-Yauh
    Wang, Sun-Sang
    Lin, Han-Chieh
    Huang, Hui-Chun
    Teng, Tzu-Hua
    Hsu, Shao-Jung
    Hsieh, Hsian-Guey
    Lee, Shou-Dong
    [J]. CLINICAL SCIENCE, 2013, 124 (7-8) : 457 - 466
  • [4] Potential antifibrotic effects of AT1 receptor antagonist, losartan, and/or praziquantel on acute and chronic experimental liver fibrosis induced by Schistosoma mansoni
    El-Lakkany, Naglaa M.
    El-Maadawy, Walaa
    Ain-Shoka, Afaf
    Badawy, Afkar
    Hammam, Olfat
    Ebeid, Fatma
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2011, 38 (10) : 695 - 704
  • [5] The influence of sorafenib on hepatic encephalopathy and the mechanistic survey in cirrhotic rats
    Hsu, Shao-Jung
    Hsin, I-Fang
    Lin, Yi-Ling
    Chen, Yi-Chen
    Huang, Hui-Chun
    Lee, Fa-Yauh
    Lin, Han-Chieh
    Chang, Ching-Chih
    Lee, Shou-Dong
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2012, 42 (12) : 1309 - 1316
  • [6] A canine portal hypertension model induced by intra-portal administration of Sephadex microsphere
    Jin, Wangxun
    Deng, Liming
    Zhang, Qiyu
    Lin, Dexin
    Zhu, Jiying
    Chen, Yunzhi
    Chen, Bicheng
    Li, Jianmin
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 (04) : 778 - 785
  • [7] Alleviation of dimethylnitrosamine-induced liver injury and fibrosis by betaine supplementation in rats
    Kim, Sang K.
    Seo, Jung M.
    Chae, Yu R.
    Jung, Young S.
    Park, Jae H.
    Kim, Young C.
    [J]. CHEMICO-BIOLOGICAL INTERACTIONS, 2009, 177 (03) : 204 - 211
  • [8] Silymarin retards the progression of alcohol-induced hepatic fibrosis in baboons
    Lieber, CS
    Leo, MA
    Cao, Q
    Ren, CL
    DeCarli, LM
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2003, 37 (04) : 336 - 339
  • [9] Animal models of chronic liver diseases
    Liu, Yan
    Meyer, Christoph
    Xu, Chengfu
    Weng, Honglei
    Hellerbrand, Claus
    ten Dijke, Peter
    Dooley, Steven
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2013, 304 (05): : G449 - G468
  • [10] Personalized treatment of hepatitis
    Lok, Anna S.
    [J]. CLINICAL AND MOLECULAR HEPATOLOGY, 2015, 21 (01) : 1 - 6